Comprehensive Assessment of Morphometric, Functional, Biomechanical and Biological Interactions Between Atherosclerotic Plaque and Platelets Within the Stenosed Coronary Artery
NCT ID: NCT06275399
Last Updated: 2024-02-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
105 participants
OBSERVATIONAL
2023-07-21
2026-07-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vessel Imaging Using Optical Coherence Tomography for Plaque Morphology and Vessel Fractional Flow Reserve
NCT06844942
Multimodality Imaging and Functional Lesion Assessment in Intermediate Coronary Stenosis in Chronic Coronary Syndrome
NCT06261866
Combined Pressure and Flow Measurements to Guide Treatment of Coronary Stenoses
NCT02328820
Relationship Between Pressure and Flow Velocity on Coronary Physiology
NCT02330861
Prediction of Atherosclerotic Plaque Progression
NCT05424705
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The groups will be assessed at the time of angiography with:
* OCT examination for precise evaluation of plaque morphology within the coronary stenosis
* Computational fluid dynamics with vFFR and estimation of value and distribution of shear rate and shear stress
* Impedance aggregometry-based platelet reactivity
* Single-particle high-resolution flow cytometry analysis of platelet-derived microvesicles and small extracellular vesicles (sEVs) as well as additional platelet activation (P-selectin, annexin-V) and inflammatory biomarkers
* Proteomic and metabolomic characterization - in the subset of patients Biomarker assessment will be done in the blood sampled directly from coronary artery (proximal and distal segment).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with chronic coronary syndrome and coronary stenosis (30% - 90%) amenable to OCT imaging
Patients with chronic coronary syndrome and coronary stenosis (30% - 90%) amenable to OCT imaging. The groups will be assessed at the time of angiography with:
* OCT for evaluation of plaque morphology within the coronary stenosis
* Computational fluid dynamics with vFFR and estimation of value and distribution of shear rate and shear stress
* Impedance aggregometry based platelet reactivity
* Single-particle high-resolution flow cytometry analysis of pMVs and sEVs as well as additional platelet activation and inflammatory biomarkers
* Proteomic and metabolomic characterization - in the subset of patients
Biomarker assessment will be done in the blood sampled directly from coronary artery (proximal and distal segment) arteries. Shear rate/shear stress distribution and biomarkers profile will be compared between the stenotic vessel and the non-stenotic vessel (stenoses \<30%) in the same patient.
OCT examination
OCT examination for precise evaluation of plaque morphology within the coronary stenosis.
Blood sampling
Blood sampling directly from coronary artery (proximal and distal segment) arteries
Assessment of vFFR and shear stress parameters
The procedure is based on non-invasive assessment of vFFR and shear stress parameters with dedicated software, deriving parameters directly from coronary angiography with the calculation based on the computational fluid dynamics
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
OCT examination
OCT examination for precise evaluation of plaque morphology within the coronary stenosis.
Blood sampling
Blood sampling directly from coronary artery (proximal and distal segment) arteries
Assessment of vFFR and shear stress parameters
The procedure is based on non-invasive assessment of vFFR and shear stress parameters with dedicated software, deriving parameters directly from coronary angiography with the calculation based on the computational fluid dynamics
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Angiographically confirmed coronary stenosis (30% - 90%)
* Amenable to OCT imaging
Exclusion Criteria
* ST-segment elevation or non-ST-segment elevation myocardial infarction
* Active bleeding
* Left main coronary artery disease
* Multivessel disease
* Lesions located at a distance ≤3 mm from the ostium of the vessel
* Thrombocytopenia
* Previous coronary artery bypass grafting
* Previous coronary intervention with stent implantation or balloon angioplasty
* Previous use of novel oral anticoagulants or vitamin K antagonists
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Science Centre, Poland
OTHER_GOV
University College, London
OTHER
Queen Mary University of London
OTHER
Medical University of Warsaw
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mariusz Tomaniak
Tomaniak Mariusz MD PhD Assoc. Prof.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical University of Warsaw
Warsaw, Masovian Voivodeship, Poland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
INTERFORCE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.